MedLumics raises €18 million for atrial fibrillation device

MedLumics has raised another €18 million (around $22 million) to fund clinical trials of its optically-guided imaging system used to guide a surgical procedure for

iRhythm digital heart monitoring service backed by NICE

A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies.

RHYTHM AI cleared for large trial of atrial fibrillation map...

UK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, which could be used as a treatment for atrial fibrillation without the need

AI study will help select AFib patients for shock treatment

AI-driven atrial fibrillation project begins after seed fund...

Clinical development of an AI-driven system that identifies the sources or drivers of atrial fibrillation (AF), and could prevent the need for medication, has got off the ground after the p

Lixiana hits the mark in catheter ablation trial

Daiichi Sankyo’s Lixiana was a late entrant to the novel oral anticoagulant (NOAC) category, but the Japanese drugmaker hopes new data in atrial fibrillation (AFib) could accelerate its gro